Fri, Nov 28, 2014, 10:50 AM EST - U.S. Markets close early today in 2 hrs 10 mins for The day after Thanksgiving


% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • kevinmik kevinmik Apr 11, 2014 4:47 PM Flag

    Dance Pharmaceutical Seems Is Dancing Around In Circles :)

    The company's supposed novel new inhaled product that's expected to compete one day against Afrezza is nothing more than Exubera being developed using a new 2nd generation delivery device. The developers at Dance Pharmaceutical are former Nektar employees that worked on the original Exubera program and they are now looking to improve some of Exubera's short comings by offering a better delivery device at a lower cost. Outside of those improvement, Dance's new inhaled insulin is not looking to delivery a better insulin that in ultra-rapid acting like Afrezza and they are looking to target the Type II market. Bottom-line Dance is developing just another rapid acting insulin that will not offer any additional benefits over current injected rapid acting insulin drugs with the and they seem to be targeting convenience as being the biggest selling point. This product appears might be dead before it even gets out of the gate. If you want to find out more information google or yahoo search the following article:
    "Dance Pharmaceuticals Gives Inhaled Insulin a “Do-Over” (Exubera 3.0?).

    SortNewest  |  Oldest  |  Most Replied Expand all replies
6.27+0.01(+0.16%)10:49 AMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.